SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ:CYTX) received Notification of Issuance from the United States Patent & Trademark Office for its core patent covering the Celution® System (USPTO # 7,390,484). This patent protects Cytori’s key device technology, which processes adult stem and regenerative cells from adipose tissue at the patient’s bedside.
